Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:498700rdf:typepubmed:Citationlld:pubmed
pubmed-article:498700lifeskim:mentionsumls-concept:C0004238lld:lifeskim
pubmed-article:498700lifeskim:mentionsumls-concept:C0004239lld:lifeskim
pubmed-article:498700lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:498700pubmed:issue5lld:pubmed
pubmed-article:498700pubmed:dateCreated1980-1-28lld:pubmed
pubmed-article:498700pubmed:abstractTextA double-blind randomized study was performed to compare the efficacy of intravenous verapamil with saline in 28 patients with a rapid ventricular rate and atrial fibrillation or atrial flutter. Conversion of atrial fibrillation to sinus rhythm occurred in none of 14 patients after saline and in 3 of 20 patients (15%) 7 to 160 min after verapamil. The ventricular rate in atrial fibrillation was slowed greater than or equal to 15% in 2 of 14 patients (14%) by saline, in 17 of 20 patients (85%) by 1 dose of verapamil (p less than 0.001), and in 19 of 20 patients (95%) by 1 or 2 doses of verapamil (p less than 0.001). Conversion of atrial flutter to sinus rhythm occurred in none of 4 patients after saline and in 1 of 7 patients (14%) 105 min after verapamil. The ventricular rate in atrial flutter was slowed greater than or equal to 15% in none of 4 patients by saline, in 4 of 7 patients (57%) by 1 dose of verapamil, and in 7 of 7 patients (100%) by 1 or 2 doses of verapamil (p less than 0.001).lld:pubmed
pubmed-article:498700pubmed:languageenglld:pubmed
pubmed-article:498700pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:498700pubmed:citationSubsetAIMlld:pubmed
pubmed-article:498700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:498700pubmed:statusMEDLINElld:pubmed
pubmed-article:498700pubmed:monthNovlld:pubmed
pubmed-article:498700pubmed:issn0009-9236lld:pubmed
pubmed-article:498700pubmed:authorpubmed-author:AronowW SWSlld:pubmed
pubmed-article:498700pubmed:authorpubmed-author:FerlinzJJlld:pubmed
pubmed-article:498700pubmed:authorpubmed-author:LandeHHlld:pubmed
pubmed-article:498700pubmed:authorpubmed-author:WongRRlld:pubmed
pubmed-article:498700pubmed:authorpubmed-author:KarlsbergR...lld:pubmed
pubmed-article:498700pubmed:authorpubmed-author:PlasenciaGGlld:pubmed
pubmed-article:498700pubmed:issnTypePrintlld:pubmed
pubmed-article:498700pubmed:volume26lld:pubmed
pubmed-article:498700pubmed:ownerNLMlld:pubmed
pubmed-article:498700pubmed:authorsCompleteYlld:pubmed
pubmed-article:498700pubmed:pagination578-83lld:pubmed
pubmed-article:498700pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-H...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-A...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-A...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-E...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-M...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-A...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-A...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-M...lld:pubmed
pubmed-article:498700pubmed:meshHeadingpubmed-meshheading:498700-V...lld:pubmed
pubmed-article:498700pubmed:year1979lld:pubmed
pubmed-article:498700pubmed:articleTitleVerapamil in atrial fibrillation and atrial flutter.lld:pubmed
pubmed-article:498700pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:498700pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:498700pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:498700pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:498700lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:498700lld:pubmed